2019 Community Individual Patients 
Annals of Family Medicine
NOVEMBER 20, 2024
Context Social Prescribing (SP) is an approach to help individuals address their health and social needs wherein a healthcare practitioner refers patients to non-clinal services in the community. Models of SP vary, and the experience of patients across these models is less known.
Integrated Care News by CFHA
MAY 19, 2025
MBC entails equal emphasis on the phases of Collect, Share, and Act , which include repeated data gathering, communication/review of the data with the patient and team, and adjusting treatment based on this information. (2) MBC enhances therapeutic alliance and improves culturally informed care to diverse patient groups. (10,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
APRIL 3, 2023
During this episode, we hear from Dr. Nav Persaud, a staff physician in the Department of Family and Community Medicine at St. The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon.
BMJ
JULY 17, 2020
A multilayered view of stigmatizing discourses lays the foundation for eliciting a series of suggestions for quelling stigma, to be implemented at the individual, community, and national levels, as suggested by the WHO. Yet, as Tenkorang 7 made the point, it is simply not enough to only implement approaches at the community level.
FDA Law
JUNE 23, 2021
Valentine — For the last 13 years, this blogger has been at the center of what has now been dubbed “patient-focused drug development.” For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. By James E. The practice of medicine was viewed as paternalistic.
The Clinical Problem Solvers
DECEMBER 16, 2020
19:05 Clarifying the “ethics vs science” argument and critiquing research techniques 22:00 Resurgence of race-based speculation in COVID-19-related research 25:57 Implantation of ideas about innate racial inferiority within medicine 28:32 Will removal of race from algorithms potentially harm our patients?
FDA Law
JANUARY 6, 2022
Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. EKRA is codified at 18 U.S.C. § 220 and was described on HP&M’s blog here. 18 U.S.C. § 24(b) (emphasis added).
Expert insights. Personalized for you.
130 
Let's personalize your content